Referencias bibliográficas

  1. Garbicz J, Całyniuk B, Górski M, Buczkowska M, Piecuch M, Kulik A, Rozentryt P. Nutritional Therapy in Persons Suffering from Psoriasis. Nutrients. 2021 Dec 28;14(1):119. doi: 10.3390/nu14010119. PMID: 35010995; PMCID: PMC8747310.
  2.  Zuccotti E, Oliveri M, Girometta C, Ratto D, Di Iorio C, Occhinegro A, Rossi P. Nutritional strategies for psoriasis: current scientific evidence in clinical trials. Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8537-8551. doi: 10.26355/eurrev_201812_16554. PMID: 30556896.
  3. Rendon A, Schäkel K. Psoriasis Pathogenesis and Treatment. Int J Mol Sci. 2019 Mar 23;20(6):1475. doi: 10.3390/ijms20061475. PMID: 30909615; PMCID: PMC6471628.
  4. Valle LE. Dermatología General. Enfoque Práctico. Tercera Edición. Editorial Dunken. Buenos Aires. Argentina. 2019.
  5. Katsimbri P, Korakas E, Kountouri A, Ikonomidis I, Tsougos E, Vlachos D, Papadavid E, Raptis A, Lambadiari V. The Effect of Antioxidant and Anti-Inflammatory Capacity of Diet on Psoriasis and Psoriatic Arthritis Phenotype: Nutrition as Therapeutic Tool? Antioxidants (Basel). 2021 Jan 22;10(2):157. doi: 10.3390/antiox10020157. PMID:33499118; PMCID: PMC7912156.
  6. Moudgil KD, Venkatesha SH. The Anti-Inflammatory and Immunomodulatory Activities of Natural Products to Control Autoimmune Inflammation. Int J Mol Sci. 2022 Dec 21;24(1):95. doi: 10.3390/ijms24010095. PMID: 36613560; PMCID: PMC9820125.
  7. Musumeci ML, Nasca MR, Boscaglia S, Micali G. The role of lifestyle and nutrition in psoriasis: Current status of knowledge and interventions. Dermatol Ther. 2022 Sep;35(9):e15685. doi: 10.1111/dth.15685. Epub 2022 Jul 18. PMID: 35790061; PMCID: PMC9541512.
  8. Dand N, Mahil SK, Capon F, Smith CH, Simpson MA, Barker JN. Psoriasis and Genetics. Acta Derm Venereol. 2020 Jan 30;100(3):adv00030. doi: 10.2340/00015555-3384. PMID: 31971603; PMCID: PMC9128944.
  9. Ramessur R, Corbett M, Marshall D, Acencio ML, Barbosa IA, Dand N, Di Meglio P, Haddad S, Jensen AHM, Koopmann W, Mahil SK, Ostaszewski M, Rahmatulla S, Rastrick J, Saklatvala J, Weidinger S, Wright K, Eyerich K, Ndlovu M, Barker JN, Skov L, Conrad C, Smith CH; BIOMAP consortium. Biomarkers of disease progression in people with psoriasis: a scoping review. Br J Dermatol. 2022 Oct;187(4):481-493. doi:10.1111/bjd.21627. Epub 2022 Jul 11. PMID: 35482474; PMCID: PMC9796834.
  10. Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk Factors for the Development of Psoriasis. Int J Mol Sci. 2019 Sep 5;20(18):4347. doi:10.3390/ijms20184347. PMID: 31491865; PMCID: PMC6769762.
  11. Seirafianpour F, Pourriyahi H, Gholizadeh Mesgarha M, Pour Mohammad A, Shaka Z, Goodarzi A. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders. Dermatol Ther. 2022 Jun;35(6):e15461. doi:10.1111/dth.15461. Epub 2022 Apr 11. PMID: 35316551; PMCID: PMC9111423. Https://pubmed.ncbi.nlm.nih.gov/35316551/.
  12. Gisondi P, Geat D, Bellinato F, Spiazzi L, Danese E, Montagnana M, Lippi G, Girolomoni G. Psychological Stress and Salivary Cortisol Levels in Patients with Plaque Psoriasis. J Pers Med. 2021 Oct 23;11(11):1069. doi: 10.3390/jpm11111069. PMID:34834421; PMCID: PMC8621977.
  13. Pietrzak R, Rykowski P, Pasierb A, Bartoszewicz Z, Stakun M, Rykowska M, Karoń K, Rudnicka L, Czuwara J. Adrenocorticotropin/cortisol ratio – a marker of psoriasis severity. Postepy Dermatol Alergol. 2020 Oct;37(5):746-750. doi:10.5114/ada.2019.83975. Epub 2019 Apr 9. PMID: 33240015; PMCID: PMC7675074.
  14. López Gamboa, Y., Pérez Ruiz, M.E., & Artega Yanez, Y.L. (2021). Relación Entre los Ritmos Circadianos y la Obesidad. Revista Científica Hallazgos21, 6(2), 225- 235.
  15. Calvo Fernández JR, Gianzo Citores M. Los relojes biológicos de la alimentación. Nutr Hosp 2018;35 (N.o Extra. 4):33-38 DOI: http://dx.doi.org/10.20960/nh.2122.
  16. Neema S, Sandhu S, Gupta A. Opciones de tratamiento no convencionales en la psoriasis: una revisión. Ind Jour Derm, Vene Lepro IJDL 2021; 88(2);137-143.
  17. Buhaș MC, Gavrilaș LI, Candrea R, Cătinean A, Mocan A, Miere D, Tătaru A. Gut Microbiota in Psoriasis. Nutrients. 2022 Jul 20;14(14):2970. doi: 10.3390/nu14142970. PMID: 35889927; PMCID: PMC9321451.
  18. Chen G, Chen ZM, Fan XY, Jin YL, Li X, Wu SR, Ge WW, Lv CH, Wang YK, Chen JG. Gut-Brain-Skin Axis in Psoriasis: A Review. Dermatol Ther (Heidelb). 2021 Feb;11(1):25-38. doi: 10.1007/s13555-020-00466-9. Epub 2020 Nov 18. PMID:33206326; PMCID: PMC7859123.
  19. Seirafianpour F, Pourriyahi H, Mesgarha MG y col. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of importan immune-mediated dermatologic disorders. Dermatol Therap. 2022;35:e15461. Https://doi.org/10.1111/dth.15461.
  20. Wacewicz-Muczyńska M, Socha K, Soroczyńska J, Niczyporuk M, Borawska MH. Cadmium, lead and mercury in the blood of psoriatic and vitiligo patients and their possible associations with dietary habits. Sci Total Environ. 2021 Feb 25;757:143967. doi: 10.1016/j.scitotenv.2020.143967. Epub 2020 Dec 3. PMID: 33302005.
  21. Hahn J, Cook NR, Alexander EK, Friedman S, Walter J, Bubes V, Kotler G, Lee IM, Manson JE, Costenbader KH. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ. 2022 Jan 26;376:e066452. doi: 10.1136/bmj-2021-066452. PMID: 35082139; PMCID:PMC8791065.
  22. Kocic H, Damiani G, Stamenkovic B, Tirant M, Jovic A, Tiodorovic D, Peris K. Dietary compounds as potential modulators of microRNA expression in psoriasis. Ther Adv Chronic Dis. 2019 Aug 7;10:2040622319864805. doi: 10.1177/2040622319864805. PMID: 31431821; PMCID: PMC6686315.
  23. Álvarez Calatayud G, Guarner Aguilar F. Microbiota, probióticos y prebióticos. Evidencia científica. SEMiPyP (ERGON). 2022; (1): 424-425.
  24. Tammy Born, Christina N. Kontoghiorghe, Aspasia Spyrou, Annita Kolnagou & George J. Kontoghiorghes (2013) EDTA chelation reappraisal following new clinical trials and regular use in millions of patients: review of preliminary findings and risk/benefit assessment, Toxicology Mechanisms and Methods, 23:1, 11-17, DOI:10.3109/15376516.2012.730562.